Tumor biology or adjuvant systemic therapy: what determines the risk of recurrence in breast cancer stage I?
- Authors: Kolyadina IV1,2, Poddubnaya IV1,2, Trofimova OP1,2, Frank GA1, Karseladze AI3, Komov DV3
-
Affiliations:
- Department of Oncology, Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia (125993, Barricadnaya st. 2/1, Moscow, Russia)
- 2N.N.Blokhin Russian Cancer Research Center (RCRC) (115478, Kashirskoe shosse, 24, Moscow, Russia)
- N.N.Blokhin Russian Cancer Research Center (RCRC) (115478, Kashirskoe shosse, 24, Moscow, Russia)
- Issue: Vol 16, No 4 (2014)
- Pages: 24-30
- Section: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/26964
- ID: 26964
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
I V Kolyadina
Department of Oncology, Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia (125993, Barricadnaya st. 2/1, Moscow, Russia); 2N.N.Blokhin Russian Cancer Research Center (RCRC) (115478, Kashirskoe shosse, 24, Moscow, Russia)
Email: irinakolyadina@yandex.ru
канд. мед. наук, врач-онколог, доц. каф. онкологии
I V Poddubnaya
Department of Oncology, Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia (125993, Barricadnaya st. 2/1, Moscow, Russia); 2N.N.Blokhin Russian Cancer Research Center (RCRC) (115478, Kashirskoe shosse, 24, Moscow, Russia)
O P Trofimova
Department of Oncology, Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia (125993, Barricadnaya st. 2/1, Moscow, Russia); 2N.N.Blokhin Russian Cancer Research Center (RCRC) (115478, Kashirskoe shosse, 24, Moscow, Russia)
G A Frank
Department of Oncology, Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia (125993, Barricadnaya st. 2/1, Moscow, Russia)
A I Karseladze
N.N.Blokhin Russian Cancer Research Center (RCRC) (115478, Kashirskoe shosse, 24, Moscow, Russia)
D V Komov
N.N.Blokhin Russian Cancer Research Center (RCRC) (115478, Kashirskoe shosse, 24, Moscow, Russia)
References
- Minicozzi P, Bella F, Toss A et al. Relative and disease - free survival for breast cancer in relation to subtype: a population - based study. J Cancer Res Clin Oncol 2013; 139 (9): 1569-77.
- Cadoo K.A, Fornier M.N, Morris P.G. Biological subtypes of breast cancer: current concepts and implications for recurrence patterns. Q J Nucl Med Mol Imaging 2013; 57 (4): 312-21.
- Parise C.A, Bauer K.R, Brown M.M, Caggiano V. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California (1999-2004). Breast J 2009; 15 (6): 593-602.
- Pracella D, Bonin S, Barbazza R et al. Are breast cancer molecular classes predictive of survival in patients with long follow - up? Dis Markers 2013; 35 (6): 595-605.
- Wang Y, Yin Q, Yu Q et al. A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments. Breast Cancer Res Treat 2011; 130 (2): 489-98.
- García-Fernández A, Chabrera C, García-Font M et al. Differential survival and recurrence patterns of patients operated for breast cancer according to the new immunohistochemical classification: analytical survey from 1997 to 2012. Tumour Biol 2013; 34 (4): 2349-55.
- García-Fernández A, Chabrera C, García-Font M et al. Mortality and recurrence patterns of breast cancer patients diagnosed under a screening programme vs. comparable non - screened breast cancer patients from the same population: analytical survey from 2002 to 2012. Tumour Biol 2013; http://www.ncbi.nlm.nih.gov/pubmed/24114015
- Hanrahan E.O, Valero V, Gonzalez-Angulo A.M, Hortobagyi G.N. Prognosis and management of patients with node - negative invasive breast carcinoma that is 1 cm or smaller in size (stage I; T1a,bN0M0): a review of the literature. J Clin Oncol 2006; 24 (13): 2113-22.